Sun Pharmaceutical expects 18-20% sales growth in the current fiscal year that started in April, Managing Director Dilip Shanghvi said in an earnings conference call on Wednesday.
first published: May 30, 2012 11:00 am
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.